New therapies for the treatment of AIDS-related Kaposi sarcoma

Current Opinion in Oncology

Volumn 12, Issue 5, 2000, Pages 445-449

  Dezube, Bruce J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; 4 DEDIMETHYLAMINOSANCYCLINE; ALITRETINOIN; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTIRETROVIRUS AGENT; BLEOMYCIN; DAUNORUBICIN; DOXORUBICIN; FUMAGILLIN; IM 862; INTERLEUKIN 12; INTERLEUKIN 6; PACLITAXEL; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RETINOID X RECEPTOR; SEX HORMONE; THALIDOMIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CLINICAL TRIAL; CRYOTHERAPY; DISEASE COURSE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LASER SURGERY; PRIORITY JOURNAL; REVIEW; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; INTERFERON-ALPHA; LYMPHOMA, AIDS-RELATED; PACLITAXEL; SARCOMA, KAPOSI;

EID: 0034457347     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200009000-00010     Document Type: Review

References (34)

1. Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk
2. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
3. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma
4. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded inerleukin-6
5. Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: A missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma
6. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1 and human herpesvirus 8-coinfected patients
7. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
8. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir
9. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy
10. Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy
11. HAART prolongs time to treatment failure in Kaposi's sarcoma
12. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
13. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic) gel
14. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with injection
15. The role of radiation therapy in the management of HIV-related Kaposi's sarcoma
16. Palliative treatment of epidemic Kaposi sarcoma of the feet
17. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: A Canadian HIV Clinical Trials Network Study
18. Multicenter, randomized, open-label phase II trial of two doses of interferon-α2b with didanosine in HIV-related Kaposi's sarcoma: ACTG 206
19. Chemotherapy of AIDS-related Kaposi's sarcoma
20. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma
21. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
22. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
23. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
24. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
25. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
26. Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma
27. Paclitaxel in the treatment of human immunodeficiency virus-1-associated Kaposi's sarcoma-drug-drug interactions with protease inhibitors and a nonnucleoside transcriptase inhibitor: A case report study
28. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma
29. Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trial Group study
30. Activity of thalidomide in AIDS-related Kaposi's sarcoma
31. Angiogenesis inhibitor col-3 in the treatment of HIV-related Kaposi's sarcoma: A phase I AIDS Malignancy Consortium study
32. Administration of interleukin-12 to patients with AIDS-associated Kaposi's sarcoma: Preliminary results of a pilot study
33. Oral 9-cis-retinoic acid is active in AIDS related Kaposi's sarcoma: AIDS Malignancy Consortium study 002
34. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma